Business

A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than Merck‘s Keytruda in a clinical trial. The company, Summit Therapeutics, licensed the drug from Chinese company Akeso Inc.  In October, a group of life science investors announced they were putting $400
0 Comments
In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s
0 Comments
In this article FOXA Follow your favorite stocksCREATE FREE ACCOUNT Philadelphia Eagles head coach Nick Sirianni and quarterback Jalen Hurts celebrate with the Vince Lombardi Trophy after winning Super Bowl 59. Mike Segar | Reuters The Philadelphia Eagles weren’t the only ones that scored big at the Super Bowl. The National Football League’s championship game
0 Comments